Our lab studies the mechanisms that govern glycan immune recognition and responses in animal models and humans, both in vitro and in vivo. We combine glycobiology, immunology, biotechnology, xenotransplantation, cancer research, medicine, and use cutting-edge technologies within these disciplines, including in silico and in vitro antibody engineering, cell and gene therapy, glycan microarray and glyco-nanotechnology. As members of the Cancer Biology Research Center (CBRC), we also investigate cancer prevention, diagnostics and therapy.
2013 FP7-HEALTH-2013-INNOVATION, European Commission
2013 Marie Curie Incoming International Fellowship, European Commission
2016 ERC Starting Grant, European Research Council
2020 ERC Proof of Concept Grant, European Research Council
2022 ERC Proof of Concept Grant, European Research Council
2022 ISEF Award for excellence in science and social leadership volunteering
2023 ERC Consolidator Grant, European Research Council